Puyu Shi

1.0k total citations
33 papers, 793 citations indexed

About

Puyu Shi is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Puyu Shi has authored 33 papers receiving a total of 793 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Puyu Shi's work include Lung Cancer Treatments and Mutations (8 papers), RNA modifications and cancer (7 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Puyu Shi is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), RNA modifications and cancer (7 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Puyu Shi collaborates with scholars based in China, United States and Australia. Puyu Shi's co-authors include Shi‐Yong Sun, Suresh S. Ramalingam, Hui Ren, Taofeek K. Owonikoko, Mingwei Chen, Guojing Zhang, Yang Tian, Mingwei Chen, You-Take Oh and Shuo Zhang and has published in prestigious journals such as Cancer, Cancer Research and Oncogene.

In The Last Decade

Puyu Shi

32 papers receiving 791 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Puyu Shi China	16	539	319	235	202	88	33	793
Yiqian Liu China	17	514 1.0×	204 0.6×	213 0.9×	370 1.8×	47 0.5×	53	881
Rachel Sexton United States	15	575 1.1×	208 0.7×	247 1.1×	235 1.2×	76 0.9×	30	930
Wei Jing China	16	341 0.6×	199 0.6×	269 1.1×	111 0.5×	39 0.4×	45	694
Yuxi Shan China	20	475 0.9×	284 0.9×	138 0.6×	268 1.3×	44 0.5×	62	1.0k
Sara Baglivo Italy	17	306 0.6×	541 1.7×	661 2.8×	187 0.9×	63 0.7×	39	993
Ildiko Csiki United States	9	229 0.4×	104 0.3×	203 0.9×	121 0.6×	40 0.5×	25	663
Michela Piezzo Italy	11	245 0.5×	235 0.7×	279 1.2×	174 0.9×	41 0.5×	20	679
Silvio Ken Garattini Italy	13	278 0.5×	180 0.6×	279 1.2×	78 0.4×	46 0.5×	42	733
Lijuan Fang China	12	320 0.6×	141 0.4×	149 0.6×	122 0.6×	29 0.3×	42	645
Anna M. Azarova United States	8	743 1.4×	132 0.4×	502 2.1×	86 0.4×	90 1.0×	9	1.2k

Countries citing papers authored by Puyu Shi

Since Specialization

Citations

This map shows the geographic impact of Puyu Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Puyu Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Puyu Shi more than expected).

Fields of papers citing papers by Puyu Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Puyu Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Puyu Shi. The network helps show where Puyu Shi may publish in the future.

Co-authorship network of co-authors of Puyu Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Puyu Shi. A scholar is included among the top collaborators of Puyu Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Puyu Shi. Puyu Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shi, Puyu, Lisa Liu, Gill Livingston, et al.. (2025). Social cognition in mild cognitive impairment and dementia: A systematic review and meta‐analysis. Alzheimer s & Dementia. 21(3). e70076–e70076. 3 indexed citations

Fan, Meng, Meng Li, Anqi Li, et al.. (2025). Clinical value of serum PRDM16 in early diagnosis and prognosis assessment of lung adenocarcinoma. Molecular Biology Reports. 52(1). 225–225.

Zhang, Yamin, Zhou Meng, Rong Liang, et al.. (2025). Mental health literacy and the stigmatisation and discrimination of individuals affected by mental illnesses in China: a scoping review. The Lancet Regional Health - Western Pacific. 61. 101642–101642. 1 indexed citations

Zhang, Kun, et al.. (2024). Plasma genome-wide mendelian randomization identifies potentially causal genes in idiopathic pulmonary fibrosis. Respiratory Research. 25(1). 379–379. 2 indexed citations

Han, Peng, Yixing Li, Xinru Li, et al.. (2024). MiR-183-5p inhibits lung squamous cell carcinoma survival through disrupting hypoxia adaptation mediated by HIF-1α/NDUFA4L2 axis. Oncogene. 43(38). 2821–2834. 3 indexed citations

Chen, Gang, Y. Wu, G. Zhang, et al.. (2024). 1475TiP Fruquintinib in combination with sintilimab and CAPEOX as first-line treatment for advanced G/GEJ cancer: A phase Ib/II clinical trial (FUNCTION). Annals of Oncology. 35. S911–S911. 1 indexed citations

Zheng, Ya, et al.. (2023). Contextual valence influences the neural dynamics of time and magnitude representation during feedback evaluation. Psychophysiology. 60(10). e14335–e14335. 7 indexed citations

Liang, Yiqian, Ting Wang, Xi Jia, et al.. (2022). Fucosyltransferase 8 is Overexpressed and Influences Clinical Outcomes in Lung Adenocarcinoma Patients. Pathology & Oncology Research. 28. 1610116–1610116. 5 indexed citations

Li, Meng, Hui Ren, Na Liu, et al.. (2022). MECOM/PRDM3 and PRDM16 Serve as Prognostic-Related Biomarkers and Are Correlated With Immune Cell Infiltration in Lung Adenocarcinoma. Frontiers in Oncology. 12. 772686–772686. 12 indexed citations

10.

Deng, Liang, et al.. (2021). MET inhibition downregulates DR4 expression in MET-amplified lung cancer cells with acquired resistance to EGFR inhibitors through suppressing AP-1-mediated transcription. Neoplasia. 23(8). 766–774. 9 indexed citations

11.

Zhang, Shuo, Zhen Chen, Puyu Shi, et al.. (2021). Downregulation of death receptor 4 is tightly associated with positive response of EGFR mutant lung cancer to EGFR-targeted therapy and improved prognosis. Theranostics. 11(8). 3964–3980. 22 indexed citations

12.

Li, Meng, Ke Wang, Meng Fan, et al.. (2021). Ferroptosis-Related Genes in Bronchoalveolar Lavage Fluid Serves as Prognostic Biomarkers for Idiopathic Pulmonary Fibrosis. Frontiers in Medicine. 8. 693959–693959. 32 indexed citations

13.

Shi, Puyu, Jun Yang, Zhiqiang Li, et al.. (2020). Clinical characteristics of imported and second-generation coronavirus disease 2019 (COVID-19) cases in Shaanxi outside Wuhan, China: a multicentre retrospective study. Epidemiology and Infection. 148. e238–e238. 30 indexed citations

14.

Tian, Yang, et al.. (2020). Downregulation of circEPSTI1 represses the proliferation and invasion of non-small cell lung cancer by inhibiting TRIM24 via miR-1248 upregulation. Biochemical and Biophysical Research Communications. 530(1). 348–354. 16 indexed citations

15.

Tian, Yang, Hong Li, Tianjun Chen, et al.. (2019). LncRNA MALAT1 Depressed Chemo-Sensitivity of NSCLC Cells through Directly Functioning on miR-197-3p/p120 Catenin Axis.. Europe PMC (PubMed Central). 42(3). 270–283. 69 indexed citations

16.

Liang, Yiqian, Peng Han, Ting Wang, et al.. (2019). Stage-associated differences in the serum N- and O-glycan profiles of patients with non-small cell lung cancer. Clinical Proteomics. 16(1). 20–20. 33 indexed citations

17.

Shi, Puyu, You-Take Oh, Liang Deng, et al.. (2017). Overcoming Acquired Resistance to AZD9291, A Third-Generation EGFR Inhibitor, through Modulation of MEK/ERK-Dependent Bim and Mcl-1 Degradation. Clinical Cancer Research. 23(21). 6567–6579. 113 indexed citations

18.

Shi, Puyu, You-Take Oh, Guojing Zhang, et al.. (2016). Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment. Cancer Letters. 380(2). 494–504. 147 indexed citations

19.

Zhang, Shuo, Lei Gao, Asmitananda Thakur, et al.. (2016). miRNA-204 suppresses human non-small cell lung cancer by targeting ATF2. Tumor Biology. 37(8). 11177–11186. 36 indexed citations

20.

Liang, Yiqian, Tianran Ma, Asmitananda Thakur, et al.. (2014). Differentially expressed glycosylated patterns of α-1-antitrypsin as serum biomarkers for the diagnosis of lung cancer. Glycobiology. 25(3). 331–340. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact